Advertisement

Topic - Novavax Inc.

Related Stories

In this file photo, a vial of the Phase 3 Novavax coronavirus vaccine prepared for use in a trial at St. George's University hospital in London, Oct. 7, 2020. The Food and Drug Administration authorized the COVID-19 vaccine from Novavax for emergency use on Wednesday, July 13, 2022, providing the U.S. with a fourth option. (AP Photo/Alastair Grant) **FILE**

Study finds Novavax COVID jab safe, effective for adolescents

By Sean Salai - The Washington Times

Novavax trials highlight Maryland’s COVID-fighting complex

By RACHEL LOGAN and JULIA ARBUTUS AND PIERCE PANAGAKOS of Capital News Service - Associated Press

In this Tuesday, May 26, 2020, photo released by Nucleus Network/ABC, clinical trial participants are monitored during Novavax COVID-19 vaccine testing in Melbourne, Australia. On Thursday, Jan. 28, 2021, Novavax said its vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not quite as well — against new mutated strains of the coronavirus circulating in that country and South Africa. (Patrick Rocca/Nucleus Network/ABC via AP)

Novavax COVID-19 vaccine works, but less so against variants

By Lauran Neergaard - Associated Press